9-[(3Z,5E)-7-methylidene-9,10-dipyridin-2-yl-2H-1-benzoxonin-5-yl]-3-(2-pyridin-2-ylphenyl)carbazole
C46H32N4O — CID 118563542
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-[(3Z,5E)-7-methylidene-9,10-dipyridin-2-yl-2H-1-benzoxonin-5-yl]-3-(2-pyridin-2-ylphenyl)carbazole
9-[(3Z,5E)-7-methylidene-9,10-dipyridin-2-yl-2H-1-benzoxonin-5-yl]-3-(2-pyridin-2-ylphenyl)carbazole (PubChem CID 118563542) has the molecular formula C46H32N4O and a molecular weight of 656.79 g/mol. Its IUPAC name is 9-[(3Z,5E)-7-methylidene-9,10-dipyridin-2-yl-2H-1-benzoxonin-5-yl]-3-(2-pyridin-2-ylphenyl)carbazole.
Molecular Properties
| Compound Name | 9-[(3Z,5E)-7-methylidene-9,10-dipyridin-2-yl-2H-1-benzoxonin-5-yl]-3-(2-pyridin-2-ylphenyl)carbazole |
|---|---|
| PubChem CID | 118563542 |
| Molecular Formula | C46H32N4O |
| Molecular Weight | 656.79 g/mol |
| Exact Mass | 656.26 |
| IUPAC Name | 9-[(3Z,5E)-7-methylidene-9,10-dipyridin-2-yl-2H-1-benzoxonin-5-yl]-3-(2-pyridin-2-ylphenyl)carbazole |
| SMILES | C=C1/C=C(n2c3ccccc3c3cc(-c4ccccc4-c4ccccn4)ccc32)\C=C/COc2cc(-c3ccccn3)c(-c3ccccn3)cc21 |
| InChI | InChI=1S/C46H32N4O/c1-31-27-33(13-12-26-51-46-30-39(43-19-8-11-25-49-43)38(29-37(31)46)42-18-7-10-24-48-42)50-44-20-5-4-16-36(44)40-28-32(21-22-45(40)50)34-14-2-3-15-35(34)41-17-6-9-23-47-41/h2-25,27-30H,1,26H2/b13-12-,33-27+ |
| InChIKey | XCMVMLAXKGTIER-XJQFDBJQSA-N |
| XLogP | 11.15 |
| TPSA | 52.83 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 51 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 656.79 |
| LogP ≤ 5 | 11.15 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118563542 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.